BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30389354)

  • 1. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.
    Coant N; Hannun YA
    Adv Biol Regul; 2019 Jan; 71():141-146. PubMed ID: 30389354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Coant N; GarcĂ­a-Barros M; Zhang Q; Obeid LM; Hannun YA
    Oncogene; 2018 Jul; 37(28):3852-3863. PubMed ID: 29662189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramidases, roles in sphingolipid metabolism and in health and disease.
    Coant N; Sakamoto W; Mao C; Hannun YA
    Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of neutral ceramidase in the Golgi apparatus.
    Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
    J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase.
    Airola MV; Allen WJ; Pulkoski-Gross MJ; Obeid LM; Rizzo RC; Hannun YA
    Structure; 2015 Aug; 23(8):1482-1491. PubMed ID: 26190575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
    Mao C; Obeid LM
    Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
    Snider AJ; Wu BX; Jenkins RW; Sticca JA; Kawamori T; Hannun YA; Obeid LM
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):124-30. PubMed ID: 22940715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
    Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
    J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
    Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
    J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
    Tani M; Ito M; Igarashi Y
    Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of neutral ceramidase activity in vitro and in vivo.
    Simoes M; Saleh A; Choi YM; Airola MV; Haley JD; Coant N
    Anal Biochem; 2022 Apr; 643():114577. PubMed ID: 35134389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.
    Sundaram K; Mather AR; Marimuthu S; Shah PP; Snider AJ; Obeid LM; Hannun YA; Beverly LJ; Siskind LJ
    Biochem J; 2016 Mar; 473(6):743-55. PubMed ID: 26747710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids.
    Geoffroy K; Wiernsperger N; Lagarde M; El Bawab S
    J Biol Chem; 2004 Aug; 279(33):34343-52. PubMed ID: 15184394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic Mechanism of Eukaryotic Neutral Ceramidase.
    Malinina L; Brown RE
    Structure; 2015 Aug; 23(8):1371-1372. PubMed ID: 26244839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate.
    Oizumi A; Nakayama H; Okino N; Iwahara C; Kina K; Matsumoto R; Ogawa H; Takamori K; Ito M; Suga Y; Iwabuchi K
    PLoS One; 2014; 9(2):e89402. PubMed ID: 24586752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid.
    Velazquez FN; Hernandez-Corbacho M; Trayssac M; Stith JL; Bonica J; Jean B; Pulkoski-Gross MJ; Carroll BL; Salama MF; Hannun YA; Snider AJ
    Cell Signal; 2021 Mar; 79():109875. PubMed ID: 33290840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.
    Tani M; Sano T; Ito M; Igarashi Y
    J Lipid Res; 2005 Nov; 46(11):2458-67. PubMed ID: 16061940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.
    Xu R; Sun W; Jin J; Obeid LM; Mao C
    FASEB J; 2010 Jul; 24(7):2507-15. PubMed ID: 20207939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus.
    Monick MM; Cameron K; Powers LS; Butler NS; McCoy D; Mallampalli RK; Hunninghake GW
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):844-52. PubMed ID: 14742298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.